Security key
249845108
Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value (DRMA)
CUSIP: 249845108
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 292,762
- Total 13F value
- $118,779
- Share change
- +95,560
- SEC-reported price per share
- $0.41
- Number of holders
- 11
- Value change
- +$27,793
- Number of buys
- 7
- Number of sells
- 4
- Shares outstanding
- 4,021,390
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
11
Top holders
10
DRMA full security history
Ownership snapshot
Full 13F holder table
Dermata Therapeutics, Inc. SEC filings
Dermata Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of DRMA - Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Proehl Investment Venture...
Disclosed value leader
Proehl Investment Venture...
Comparable rows
0/11
Latest evidence
30 Sep 2022
3/4/5
13F
Highest disclosed value: $6,973,306
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
Proehl Investment Ventures LLC has the largest disclosed position value at $6.97M.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Proehl Investment Ventures LLC's linked filing trail.
Disclosed position value
Top 5
Proehl Investment Ventures LLC
$6.97M
Virtu Financial LLC
$37K
Thomas Insley
$34.4K
GEODE CAPITAL MANAGEMENT, LLC
$13K
WELLS FARGO & COMPANY/MN
$13K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Proehl Investment Ventures LLC |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$6,973,306
2,933,531 shares
mixed-class rows
|
— | 17 Aug 2021 |
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$37,000
70,808 shares
|
— | 30 Sep 2022 |
| Thomas Insley |
3/4/5
Chief Financial Officer
|
—
denominator unverified
|
$34,409
14,337 shares
|
— | 17 Aug 2021 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$13,000
26,666 shares
|
— | 30 Sep 2022 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
—
denominator unverified
|
$13,000
24,388 shares
|
— | 30 Sep 2022 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
denominator unverified
|
$12,000
23,565 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
292,762
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
9
Q4 2022 holders
11
Holder diff
2
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|